Hardy Reed
UTHR icon

Hardy Reed’s United Therapeutics UTHR Stock Holding History

Hardy Reed’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$667K Sell
1,231
-6
-0.5% -$3.1K 0.04% 128
2026
Q2 		$670K Buy
1,237
+5
+0.4% +$2.82K 0.04% 126
2026
Q1 		$731K Hold
1,232
– – 0.05% 113
2025
Q4 		$600K Buy
1,232
+15
+1% +$6.98K 0.04% 124
2025
Q3 		$510K Buy
1,217
+3
+0.2% +$1.01K 0.04% 139
2025
Q2 		$349K Hold
1,214
– – 0.03% 174
2025
Q1 		$374K Sell
1,214
-5
-0.4% -$1.71K 0.03% 156
2024
Q4 		$430K Buy
1,219
+5
+0.4% +$1.84K 0.04% 144
2024
Q3 		$435K Hold
1,214
– – 0.04% 148
2024
Q2 		$387K Buy
+1,214
New +$321K 0.04% 156

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Hardy Reed's UTHR Position: Q3 2026 in Review

Hardy Reed reduced its United Therapeutics (UTHR) stake by 0.49% in Q3 2026, selling an estimated $3.1K and leaving 1,231 shares worth $667K. The position accounts for 0.04% of the portfolio, ranked #128.

Hardy Reed first reported a position in UTHR in Q2 2024 and has held it in 10 quarters since. The position peaked at $731K in Q1 2026. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Hardy Reed held 1,231 shares of United Therapeutics worth $667K as of Q3 2026.
  • Hardy Reed sold 6 United Therapeutics shares in Q3 2026, an estimated $3.1K.
  • United Therapeutics made up 0.04% of Hardy Reed's portfolio in Q3 2026, its #128 holding.
  • Hardy Reed first reported a position in United Therapeutics in Q2 2024 and has held it in 10 quarters since.
  • Hardy Reed's United Therapeutics position peaked at $731K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.